Font Size: a A A
Keyword [Chemotherapy in Breast Cancer]
Result: 41 - 60 | Page: 3 of 6
41. Association Of Ki67 With Clinicopatholoical Characteristics And Efficacy Of Neoadjuvant Chemotherapy In Breast Cancer
42. Discordances In ER,PR,HER-2 And Ki67 After Neo-adjuvant Chemotherapy In Breast Cancer And Analysis Of The Correlated Influence Factor
43. The Value Of Color Doppler Ultrasound And Contrast-enhanced Ultrasound In The Assessment Of Response To Neoadjuvant Chemotherapy In Breast Cancer
44. The Meta-analysis Of The Relationship Between The Tumor Infiltrating Lymphocytes And The Curative Effect Of Neoadjuvant Chemotherapy In Breast Cancer
45. The Curative Effect And Influencing Factors Of Neoadjuvant Chemotherapy In Breast Cancer Patients
46. Study On The Consistency Of Core Needle Biopsy And Postoperative Pathological Diagnosis And The Effect On Neoadjuvant Chemotherapy In Breast Cancer
47. The Forecast Value Of Snail And E-cadherin In Neoadjuvent Chemotherapy In Breast Cancer
48. Correlation Analysis Between AKR1B10 And Adjuvant Chemotherapy In Breast Cancer
49. The Assessment Of Efficacy And Factors Related With Pathological Complete Response Of Neoadjuvant Chemotherapy In Breast Cancer
50. Neoadjuvant Chemotherapy In Breast Cancer Prognosis State Prediction System Developmentbased On Data Mining
51. Study Of The Expressions Of Ki-67,Topo?a,Her-2,Molecular Subtypes And Their Relationship With Neoadjuvant Chemotherapy In Breast Cancer
52. The Curative Effect And Influencing Factors Of Neoadjuvant Chemotherapy In Breast Cancer
53. Value Of Quantitative Analysis By Ultrasonic Elastography To Assess Liver Damage Caused By TAC Combination Chemotherapy In Breast Cancer Patients
54. The Study Of Six Dialectical Typing Of Gastrointestinal Reactions Caused By Chemotherapy In Breast Cancer
55. The Effect Of ER?PR Expression And Clinical Significance Before And After Neoadjuvant Chemotherapy In Breast Cancer
56. Effects Of Synchronous Family-centered Care Intervention On Self-perceived Burden Of Patients With Postoperative Chemotherapy In Breast Cancer
57. Genetic Variations Are Associated With The Response Or Prognosis To Chemotherapy In Breast Cancer And Small Cell Lung Cancer Patients
58. Molecular Subtypes Of Breast Cancer Associate With Response To Neoadjuvant Chemotherapy In Breast Cancer
59. The Study Of Tumors Shrinkage Mode After Neoadjuvant Chemotherapy In Breast Cancer
60. Meta-analysis Of Magnetic Resonance Imaging In Detecting Pathological Complete Remission After Neoadjuvant Chemotherapy In Breast Cancer Patients
  <<First  <Prev  Next>  Last>>  Jump to